Disclosures for "Ethical implications of detecting cognitive motor dissociation early after brain injury")
-
Mr. Heinonen has nothing to disclose.
-
Miss Carmona has nothing to disclose.
-
Kevin Doyle has nothing to disclose.
-
Ms. Grobois has nothing to disclose.
-
Miss Kruger has nothing to disclose.
-
Dr. Velazquez has nothing to disclose.
-
Ms. Vrosgou has nothing to disclose.
-
Dr. Shen has nothing to disclose.
-
Mrs. Cespedes has nothing to disclose.
-
Ms. Yazdi has nothing to disclose.
-
Dr. Ghoshal has nothing to disclose.
-
Dr. Roh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Portola Pharmaceuticals.
-
Dr. Agarwal has nothing to disclose.
-
Dr. Park has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical Care. The institution of Dr. Park has received research support from National Institutes of Health.
-
The institution of Dr. Dugdale has received research support from McDonald Agape Foundation. Dr. Dugdale has received publishing royalties from a publication relating to health care. Dr. Dugdale has received publishing royalties from a publication relating to health care. Dr. Dugdale has received personal compensation in the range of $500-$4,999 for serving as a Speaking honoraria for various lectures with Multiple organizations.
-
Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus. Dr. Claassen has stock in iCE Neurosystems. The institution of Dr. Claassen has received research support from NINDS. The institution of Dr. Claassen has received research support from McDonnel Foundation. Dr. Claassen has received publishing royalties from a publication relating to health care. Dr. Claassen has received publishing royalties from a publication relating to health care.